EDGE
Get a demo
Log In

Lantern Pharma

Recent Updates

Product updates
Sep 25, 2023
Lantern Pharma doses first patient in LP-184 Phase I study
AI Drug Discovery
Earnings/results
Aug 9, 2023
Lantern Pharma misses EPS estimate; provides update on clinical progress
AI Drug Discovery
Earnings/results
May 9, 2023
Lantern Pharma provides clinical and business updates for Q1 2023
AI Drug Discovery
Earnings/results
Mar 23, 2023
Lantern Pharma net losses widen for Q4 and 2022
AI Drug Discovery
M&A
Mar 6, 2023
Lantern Pharma forms new subsidiary, Starlight Therapeutics, to focus on CNS and brain cancer treatments
AI Drug Discovery
Earnings/results
Nov 8, 2022
Lantern Pharma to launch first-in-human Phase I clinical trials for two candidates in 2023
AI Drug Discovery

Company Brief


HQ location:
1920 McKinney Ave. 7th Floor Dallas TX USA
Founded year:
2013
Employees:
11-50
Total Funding:
USD 95.0 million
Last Funding
USD 60.0 million, Jan 2021

Funding


Investors


No investor data is available

Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.